Transcriptome-based design of antisense inhibitors potentiates carbapenem efficacy in CRE Escherichia coli. Aunins TR, Erickson KE, Chatterjee A. Proc Natl Acad Sci U S A 2020;117:30699-30709.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Aunins TR, Erickson KE, Chatterjee A. Transcriptome-based design of antisense inhibitors potentiates carbapenem efficacy in CRE Escherichia coli. Proc Natl Acad Sci U S A 2020;117:30699-30709.
PMID: 33199638